AMPH Operating Cash Flow (Statement)
Amphastar Pharmaceuticals Inc · Operating Cash Flow (Statement)
AMPH Operating Cash Flow (Statement)
Latest reported$184.61Mperiod ending
AMPH TTM Cash from Operations ($31.04M → $184.61M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AMPH operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 184,610,000 | |
| 168,878,000 | |
| 156,115,000 | |
| 152,276,000 | |
| 159,655,000 | |
| 193,172,000 | |
| 213,386,000 | |
| 208,226,000 | |
| 212,598,000 | |
| 198,412,000 | |
| 183,503,000 | |
| 174,865,000 | |
| 130,906,000 | |
| 78,798,000 | |
| 89,181,000 | |
| 114,396,000 | |
| 96,590,000 | |
| 125,934,000 | |
| 97,994,000 | |
| 74,446,000 | |
| 80,684,000 | |
| 78,614,000 | |
| 57,266,000 | |
| 46,025,000 | |
| 25,215,000 | |
| 46,849,000 | |
| 41,762,000 | |
| 45,627,000 | |
| 73,411,000 | |
| 26,221,000 | |
| 38,191,000 | |
| 38,439,000 | |
| 25,130,000 | |
| 25,171,000 | |
| 39,209,000 | |
| 43,450,000 | |
| 42,276,000 | |
| 47,028,000 | |
| 38,560,000 | |
| 27,841,000 | |
| 30,096,000 | |
| 23,273,000 | |
| 10,681,000 | |
| 19,717,000 | |
| 29,794,000 | |
| 28,225,000 | |
| 21,052,000 | |
| 17,241,000 | |
| 4,320,000 | |
| 23,680,000 | |
| 31,042,000 | |
| 34,636,000 |